DAX 15.934 0,3%  MDAX 34.587 0,2%  Dow 35.912 -0,6%  Nasdaq 15.612 0,8%  Gold 1.817 -0,1%  TecDAX 3.558 0,7%  EStoxx50 4.302 0,7%  Nikkei 28.261 -0,3%  Dollar 1,1395 -0,1%  Öl 87,3 0,9% 

Aktionärsstruktur

Inhaber in %
Freefloat 88,06
L'Oréal SA 9,36
Government Pension Fund - Global (The) 2,21
Plan d'Epargne Entreprise Sanofi Synthelabo 1,80
Dodge & Cox International Stock Fund 1,33
Vanguard Total International Stock Index Fund 1,11
Sanofi 0,79
Caisse de Dépôt & Placement du Québec 0,59
Vanguard Developed Markets Index Fund 0,58

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2017 2018 2019 2020
Personal am Ende des Jahres 106.566 104.226 100.409 99.412
Umsatz pro Mitarbeiter in Mio. EUR 0,33 0,33 0,36 0,36

Bilanz (in Mio. EUR) - Aktiva

2017 2018 2019 2020
Summe Umlaufvermögen 26.352 24.579 28.611 33.703
Summe Anlagevermögen 73.690 83.516 84.867 86.676
Summe Aktiva 99.826 111.408 112.736 114.529

Bilanz (in Mio. EUR) - Passiva

2017 2018 2019 2020
Gesamtverschuldung/ -verbindlichkeiten 15.601 24.640 25.933 23.675
Summe Fremdkapital 41.568 52.373 53.628 51.382
Summe Eigenkapital 58.258 59.035 59.108 63.147
Summe Passiva 99.826 111.408 112.736 114.529

Adresse

54, rue La Boétie, 75008 Paris
Telefon +33 (1) 53-77-40-00
Fax +33 (1) 53-77-44-03
Internet http://www.sanofi.com

Management

Alexandra Roger
Head-Securities Law & Capital Markets
Arnaud Delépine
Investor Relations Officer
Arnaud Robert
Chief Digital Officer & Executive Vice President
Barbara Lavernos
Independent Director
Bernard Charlès
Independent Director
Brendan OCallaghan
Executive Vice President & Head-Industrial Affairs
Carole Piwnica
Independent Director
Christian Senectaire
Director
Christophe Babule
Director
Claire Terrazas
Vice President-Corporate Legal Affairs
Diane D. Souza
Independent Director
Dietmar P. Berger
Chief Medical Officer & Global Head-Development
Eva Schäfer-Jansen
Investor Relations Contact
Fabienne Lecorvaisier
Independent Director
Gilles Schnepp
Independent Director
Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer & Executive Vice President
John C. Reed
EVP & Global Head-Research & Development
Julie van Ongevalle
Executive VP & Head-Consumer Healthcare
Lise Kingo
Independent Director
Marion Palme
Director
Melanie Georgina Lee
Independent Director
Natalie Bickford
Chief People Officer & Executive Vice President
Nestle Frank
Global Head-Immunology Therapeutic Research Area
Olivier Antoine M. Charmeil
Executive Vice President-General Medicines
Patrick Kron
Independent Director
Paul Hudson
Chief Executive Officer & Director
Rachel Duan
Independent Director
Serge Weinberg
Chairman
Thomas C. Südhof
Independent Director
William J. Sibold
Executive Vice President-Sanofi Genzyme